Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 3/20 | 0.44 |
| ▸ | F10 | P00742 | 2/20 | 0.44 |
| ▸ | F12 | P00748 | 1/20 | 0.44 |
| ▸ | F7 | P08709 | 1/20 | 0.44 |
| ▸ | F3 | P13726 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.41 |
| ▸ | C1S | P09871 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11693952 | 0.98 | BLM (0.46) | F2F10F12F7F3 | |
| Acetic Acid SCHEMBL3155770 | 0.89 | RAB9A (0.47) | F2F10NPC1RAB9AKMT2A | |
| SCHEMBL6830746 | 0.81 | TRPA1 (0.44) | F2F10F12F7F3 | |
| SCHEMBL10495281 | 0.81 | F2 (0.55) | F2F10F12F7F3 | |
| SCHEMBL28628789 | 0.81 | MYC (0.43) | F2F10F12F7F3 | |
| SCHEMBL2154043 | 0.81 | MYC (0.61) | F2F10F12F7F3 | |
| SCHEMBL10824573 | 0.80 | NISCH (0.39) | F2F10F7NPC1RAB9A | |
| SCHEMBL1544723 | 0.79 | PLAU (0.55) | F2F10F7NPC1RAB9A | |
| SCHEMBL4441911 | 0.79 | CYP3A4 (0.56) | TSHRACHEMAOAMAOBALDH1A1 | |
| SCHEMBL5900574 | 0.79 | TSHR (0.47) | TSHRACHEMAOAMAOBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104177298-B | Bis- substitution -4,5- dihydros -1H of 4,4--imidazoles -5- ketone, derivative and its synthetic method | 湘潭大学 | 2018-10-02 | — | — | CN | claimed |
| CN-104177298-A | 4, 4-disubstituted-4, 5-dihydro-1H-imidazole-5-one and derivatives thereof as well as synthesis method thereof | UNIV XIANGTAN | 2014-12-03 | — | — | CN | claimed |
| US-12595251-B2 | Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| EP-4569023-A1 | COMBINATION OF CATALYTIC COMPONENTS | PolyU GmbH (DE) | 2025-06-18 | — | — | EP | disclosed |
| US-20240150506-A1 | CURING AGENTS FOR FLUOROELASTOMERS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2024-05-09 | — | — | US | disclosed |
| WO-2024033348-A1 | COMBINATION OF CATALYTIC COMPONENTS | POLYU GMBH (DE) | 2024-02-15 | — | — | WO | disclosed |
| EP-4321573-A1 | COMBINATION OF CATALYTIC COMPONENTS | PolyU GmbH (DE) | 2024-02-14 | — | — | EP | disclosed |
| EP-4305096-A1 | FLUOROELASTOMERS COMPOSITION COMPRISING CURING AGENTS | Dupont Specialty Products USA, LLC (US) | 2024-01-17 | — | — | EP | disclosed |
| US-20230365606-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-16 | — | — | US | disclosed |
| CN-116324539-A | Polarizing plate and image display device | 住友化学株式会社 | 2023-06-23 | — | — | CN | disclosed |
| WO-2022192006-A1 | FLUOROELASTOMERS COMPOSITION COMPRISING CURING AGENTS | DUPONT POLYMERS, INC. (US) | 2022-09-15 | — | — | WO | disclosed |
| WO-2003068757-A1 | NOVEL PYRIDIN- AND PYRIMIDIN-DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2003-08-21 | — | — | WO | disclosed |
| US-4888350-A | ANTIFERTILITY AGENTS | GRUPPO LEPETIT S.P.A. (IT) | 1989-12-19 | — | — | US | disclosed |
| US-4459302-A | CONTRACEPTIVES | GRUPPO LEPETIT, S.P.A. (IT) | 1984-07-10 | — | — | US | disclosed |
| EP-0025321-B1 | COMPOSITION CONTAINING S-SULFONATED IMMUNOGLOBULIN AND AGGREGATION PREVENTING OR AGGREGATE DISSOCIATING AGENT THEREFOR, AND PROCESSES FOR PREPARING COMPOSITIONS CONTAINING HIGH PROPORTIONS OF MONOMERIC S-SULFONATED IMMUNOGLOBULIN | TEIJIN LIMITED (JP) | 1984-03-21 | — | — | EP | disclosed |
| US-4362661-A | BASIC AMINO ACID SALT TO PREVENT AGGREGATION | TEIJIN LIMITED (JP) | 1982-12-07 | — | — | US | disclosed |
| US-4360457-A | AMINO ACID SALT | TEIJIN LIMITED (JP) | 1982-11-23 | — | — | US | disclosed |
| US-4303592-A | SERINE PROTEASE INHIBITORS | CENTER FOR BLOOD RESEARCH, INC. (US) | 1981-12-01 | — | — | US | disclosed |
| EP-0025321-A2 | Composition containing S-sulfonated immunoglobulin and aggregation preventing or aggregate dissociating agent therefor, and processes for preparing compositions containing high proportions of monomeric S-sulfonated immunoglobulin | TEIJIN LIMITED (JP) | 1981-03-18 | — | — | EP | disclosed |
| EP-0025275-A2 | Immunoglobulin-containing composition containing an aggregation preventing or aggregate dissociating agent for the immunoglobulin, and process for preparation thereof | TEIJIN LIMITED (JP) | 1981-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595251-B2 | Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics | CLIC1, CBR3, CBR1 | F2 3549/4885F10 3471/4885F12 3335/4885 |
| US-20230365606-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OXER1, OPRD1, OXSR1 | F2 1117/4885F10 1372/4885F12 1018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.